These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 34465825
21. The influence of prostate volume on pathological outcomes after radical prostatectomy: A single-center retrospective study. Li Q, Yang Z, Wang Z, Sun J, Wen C, Yan H, Shen H, Wang W, Xu B, Xiang J, Teng X, Zhang C, Zheng X, Xie L. Medicine (Baltimore); 2023 Dec 08; 102(49):e36526. PubMed ID: 38065843 [Abstract] [Full Text] [Related]
22. Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen. Eyrich NW, Wei JT, Niknafs YS, Siddiqui J, Ellimoottil C, Salami SS, Palapattu GS, Mehra R, Kunju LP, Tomlins SA, Chinnaiyan AM, Morgan TM, Tosoian JJ. Urol Oncol; 2022 Jan 08; 40(1):4.e1-4.e7. PubMed ID: 34753659 [Abstract] [Full Text] [Related]
23. Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring? Van Praet C, Libbrecht L, D'Hondt F, Decaestecker K, Fonteyne V, Verschuere S, Rottey S, Praet M, De Visschere P, Lumen N, Uro-Oncology Group Ghent. Clin Genitourin Cancer; 2014 Jun 08; 12(3):160-6. PubMed ID: 24361055 [Abstract] [Full Text] [Related]
24. Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course? Porcaro AB, Bianchi A, Panunzio A, Gallina S, Serafin E, Tafuri A, Trabacchin N, Orlando R, Ornaghi PI, Mazzucato G, Vidiri S, D'Aietti D, Montanaro F, Brusa D, Patuzzo GM, Artoni F, Baielli A, Migliorini F, De Marco V, Veccia A, Brunelli M, Siracusano S, Cerruto MA, Antonelli A. Int Urol Nephrol; 2024 Aug 08; 56(8):2597-2605. PubMed ID: 38553619 [Abstract] [Full Text] [Related]
25. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012. Danneman D, Drevin L, Delahunt B, Samaratunga H, Robinson D, Bratt O, Loeb S, Stattin P, Egevad L. BJU Int; 2017 Jan 08; 119(1):50-56. PubMed ID: 26918298 [Abstract] [Full Text] [Related]
26. Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern. van der Slot MA, Seyrek N, Kweldam CF, den Bakker MA, Busstra MB, Gan M, Klaver S, Rietbergen JBW, van Leenders GJLH. World J Urol; 2022 Nov 08; 40(11):2723-2729. PubMed ID: 36190529 [Abstract] [Full Text] [Related]
27. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy. Takeshima Y, Yamada Y, Teshima T, Fujimura T, Kakutani S, Hakozaki Y, Kimura N, Akiyama Y, Sato Y, Kawai T, Yamada D, Kume H. BMC Cancer; 2021 May 04; 21(1):501. PubMed ID: 33947348 [Abstract] [Full Text] [Related]
29. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings. Luzzago S, de Cobelli O, Cozzi G, Peveri G, Bagnardi V, Catellani M, Di Trapani E, Mistretta FA, Pricolo P, Conti A, Alessi S, Marvaso G, Ferro M, Matei DV, Renne G, Jereczek-Fossa BA, Petralia G, Musi G. BJU Int; 2020 Jul 04; 126(1):104-113. PubMed ID: 32150328 [Abstract] [Full Text] [Related]
30. The prognostic value of 18F-PSMA-1007 PET/CT in predicting pathological upgrading of newly diagnosed prostate cancer from systematic biopsy to radical prostatectomy. Zheng A, Wang Z, Luo L, Chang R, Gao J, Wang B, Duan X. Front Oncol; 2023 Jul 04; 13():1169189. PubMed ID: 37234988 [Abstract] [Full Text] [Related]
31. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy. Gao Y, Jiang CY, Mao SK, Cui D, Hao KY, Zhao W, Jiang Q, Ruan Y, Xia SJ, Han BM. Asian J Androl; 2016 Jul 04; 18(4):639-43. PubMed ID: 26732103 [Abstract] [Full Text] [Related]
32. Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis. Herlemann A, Buchner A, Kretschmer A, Apfelbeck M, Stief CG, Gratzke C, Tritschler S. World J Urol; 2017 Oct 04; 35(10):1517-1524. PubMed ID: 28493044 [Abstract] [Full Text] [Related]
33. Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study. Fossati N, Buffi NM, Haese A, Stephan C, Larcher A, McNicholas T, de la Taille A, Freschi M, Lughezzani G, Abrate A, Bini V, Palou Redorta J, Graefen M, Guazzoni G, Lazzeri M. Eur Urol; 2015 Jul 04; 68(1):132-8. PubMed ID: 25139197 [Abstract] [Full Text] [Related]
34. Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of "regression to the mean" using routine clinical features with correlating biochemical relapse rates. Altok M, Troncoso P, Achim MF, Matin SF, Gonzalez GN, Davis JW. Asian J Androl; 2019 Jul 04; 21(6):598-604. PubMed ID: 31115364 [Abstract] [Full Text] [Related]
38. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy. Keefe DT, Schieda N, El Hallani S, Breau RH, Morash C, Robertson SJ, Mai KT, Belanger EC, Flood TA. Virchows Arch; 2015 Oct 04; 467(4):437-42. PubMed ID: 26229020 [Abstract] [Full Text] [Related]
39. [Risk factors of ISUP Modified Gleason score upgrading after radical prostatectomy]. Li XD, Qu GY, Xu N, Xue XY, Wei Y, Zheng QS, Li JF, Cai H, Lin YZ. Zhonghua Nan Ke Xue; 2016 May 04; 22(5):415-9. PubMed ID: 27416665 [Abstract] [Full Text] [Related]